Navigation Links
Cardium Announces Retirement of Director
Date:1/26/2009

ties and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium Therapeutics, Inc. Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM)

are trademarks of Tissue Repair Company.

InnerCool Therapies(R), InnerCool(R), Celsius Control System(R), RapidBlue(TM), CoolBlue(TM), Accutrol(R), Temperature Control Element(R) and TCE(R) and UroCool(TM) are trademarks of InnerCool Therapies, Inc. (other trademarks belong to their respective owners)


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
2. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
3. Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
4. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
5. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
6. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
7. Cardium Announces Follow-On Direct Investment by Institutional Investor
8. Cardium Selected for Inclusion in Russell Microcap Index
9. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
10. Cardium Launches New AWARE Clinical Study Website
11. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(N...firstday"motionsbytheU.S.BankruptcyCourtfortheDist...ekfiledavoluntarypetitionfor,reliefunderChapter11o...urt. , TheordersissuedbytheBankruptcyCourtall...heChapter11proceedings.Inparticular,the,companyrec...
(Date:11/24/2009)...I recently approved the Promega PowerPlex 16 HS Sy...enerating DNA records for the National DNA Index S...(PRWEB) -- The FBI recently approved the Promega ...es participating in, or generating DNA records for...ntly contains more than seven million profiles and...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq...,sExecutiveChairman,willpresentatthe21stAnnualPipe...,December1,2009at10:00a.m.ET. ,, Toaccesstheliv...isittheInvestorRelationssectionofGenomicHealth,swe...onnecttothewebsiteatleast15minutespriortothebeginn...
(Date:11/23/2009)... In a provocative new study, a University of Utah...ions the major cause of global warming cannot be...r society builds the equivalent of one new nuclear...t there will be any substantial near-term departur...oxide emission rates," says the new paper by Tim G...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...Biosciences,(Nasdaq: NBIX ) announces the followi... Quarter 2008 Financial Results, When: October...: http://www.videonewswire.com/event.asp?id=527...g on to the web at the address above., ...re unable to participate during the live webcast, ...
... increasing global demand for health ...Oct. 28 Boston Healthcare Associates, Inc.,today ...esident., Mr. Barak brings 16 years of pricing an...nt of global pricing and reimbursement strategies,...ide range of therapeutic,areas including oncology,...
...on of Enrollment in U.S. Phase II Study,of Nitazox...atitis C,Genotype 1, TAMPA, Fla., Oct. 28 Romark...company, today announced the presentation of studi...ting of the American,Association for the Study of ...eting(R), and the 50th Anniversary Meeting of the ...
Other Biology Technology:Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability 2Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco 2
(Date:11/24/2009)... is available in Spanish . , The presence o...of inflammatory substances in the blood, hinders t...y a research project of the University of Navarra ... at the School of Pharmacy. , The project, entit...tion to the control of body weight and inflammatio...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
(Date:11/23/2009)...lif. - By producing some of the highest resolution... scientists have a deeper understanding how biomol...ch may lead to a new treatment for kidney stones u... in the Nov. 23 online edition of the journal Pro...lores how peptides interact with mineral surfaces ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 1Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 2Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 1As Biking Popularity Grows so Must the Spotlight on Safety 48031 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 3
...ay not have to look any further than his or her ow... to a study published in the November issue of The...prepared platelets taken from the patient which ar... elbow provides more relief than more commonly-use...ten resulting in surgery, concludes study authors ...
... from the leading cause of blindness in western so.... , With the aid of a new eye instrument, they ha...ndows Popeye with his super-human strength could a... for spectacles! , Spinach and some other vegeta... a chemical called lutein, which, together with an...
...re than virtually any other type of therapy, has g...nt success but also great concerns regarding healt... (German Research Foundation, DFG) issued its firs...eveloped enormously. , Wide-ranging experiments h... risks of gene therapy. The second memorandum, whi...
Other Biology News:New biologic treatment for tennis elbow may replace surgery for chronic sufferers 2New biologic treatment for tennis elbow may replace surgery for chronic sufferers 3Why Popeye only has eyes for spinach 2Development of gene therapy 2
...ant Facility , Galaxy LIMS, Sophisticated Bioinfor...ly experienced scientists ,We offer individual sa...r full plasmids for single or double strand public...A of interest is 1.3 to 7 kilobytes long. Univers...
...around sequencing of individual research samples, ...asmids. Agencourt's world-class, high performance ...d20 bases per day. The key benefits of Agencourt'... 24 48 hour sample turnaround, industry leading s...
Whole-Genome Shotgun Sequencing from Seqwright
Full-Length "Primer Walk" Sequencing from Seqwright
Biology Products: